About Pharming Group N.V.

Company Description

Pharming is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development.

Our key strengths include the following:

- Sales growth of our commercialized asset.

- Proven rare-disease commercialization capabilities.

- Internal pipeline of product candidates.

- Transgenic Production Platform Technology.

- Data exclusivity, know-how and intellectual property.

Year founded

1988

Served area

Worldwide

Headquarters

Darwinweg 24, 2333 Leiden, Zuid-Holland – Netherlands

Shareholder information

Shares outstanding

651,443,266

IPO

Jan. 1, 2000

Stock exchange(s)

Euronext Amsterdam

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.